LU83398A1 - Composes d'etain utiles comme medicament,medicament obtenu et procede de preparation dudit medicament - Google Patents
Composes d'etain utiles comme medicament,medicament obtenu et procede de preparation dudit medicament Download PDFInfo
- Publication number
- LU83398A1 LU83398A1 LU83398A LU83398A LU83398A1 LU 83398 A1 LU83398 A1 LU 83398A1 LU 83398 A LU83398 A LU 83398A LU 83398 A LU83398 A LU 83398A LU 83398 A1 LU83398 A1 LU 83398A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- tin
- compounds
- formulas
- medicinal product
- group
- Prior art date
Links
- 150000003606 tin compounds Chemical class 0.000 title claims description 12
- 229940126601 medicinal product Drugs 0.000 title claims 4
- 238000004519 manufacturing process Methods 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 29
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 9
- 206010028980 Neoplasm Diseases 0.000 claims description 8
- 201000011510 cancer Diseases 0.000 claims description 8
- 125000004429 atom Chemical group 0.000 claims description 5
- 239000003446 ligand Substances 0.000 claims description 5
- 125000000962 organic group Chemical group 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000001905 inorganic group Chemical group 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims description 2
- 125000000129 anionic group Chemical group 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000002844 melting Methods 0.000 description 13
- 230000008018 melting Effects 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 229910052794 bromium Inorganic materials 0.000 description 6
- 230000000259 anti-tumor effect Effects 0.000 description 4
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 208000003747 lymphoid leukemia Diseases 0.000 description 3
- XVDBWWRIXBMVJV-UHFFFAOYSA-N n-[bis(dimethylamino)phosphanyl]-n-methylmethanamine Chemical compound CN(C)P(N(C)C)N(C)C XVDBWWRIXBMVJV-UHFFFAOYSA-N 0.000 description 3
- -1 nitrogenous compound Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- BOXFGLXZZLKHKA-UHFFFAOYSA-K 2,2-diphenylethyltin(3+);trihydroxide Chemical compound [OH-].[OH-].[OH-].C=1C=CC=CC=1C(C[Sn+3])C1=CC=CC=C1 BOXFGLXZZLKHKA-UHFFFAOYSA-K 0.000 description 2
- UDOPITICNQWATG-UHFFFAOYSA-N 2-[1-(4-chlorophenyl)-2,5-dioxoimidazolidin-4-yl]acetic acid Chemical compound O=C1C(CC(=O)O)NC(=O)N1C1=CC=C(Cl)C=C1 UDOPITICNQWATG-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- PBCJCAYCIIIVRA-UHFFFAOYSA-N benzyl-oxo-propyltin Chemical compound CCC[Sn](=O)CC1=CC=CC=C1 PBCJCAYCIIIVRA-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- MYYPSWTVUTUEIP-UHFFFAOYSA-N butyl-(2-chloroethyl)-oxotin Chemical compound ClCC[Sn](CCCC)=O MYYPSWTVUTUEIP-UHFFFAOYSA-N 0.000 description 2
- CUGVIQKWJHTLQN-UHFFFAOYSA-N butyl-oxo-phenyltin Chemical compound CCCC[Sn](=O)C1=CC=CC=C1 CUGVIQKWJHTLQN-UHFFFAOYSA-N 0.000 description 2
- KSKDYXPDZBGCSA-UHFFFAOYSA-M chloro-bis(2-methylphenyl)tin Chemical compound CC1=CC=CC=C1[Sn](Cl)C1=CC=CC=C1C KSKDYXPDZBGCSA-UHFFFAOYSA-M 0.000 description 2
- OCRRXQDJWXOSCL-UHFFFAOYSA-L cyclohexyl(phenyl)tin(2+);dichloride Chemical compound C=1C=CC=CC=1[Sn](Cl)(Cl)C1CCCCC1 OCRRXQDJWXOSCL-UHFFFAOYSA-L 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- MPXPGCBVGMIVLD-UHFFFAOYSA-N ethyl-oxo-phenyltin Chemical compound CC[Sn](=O)C1=CC=CC=C1 MPXPGCBVGMIVLD-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- FLHJWTVEWXPCJX-UHFFFAOYSA-K 2,2-diphenylethyl(triiodo)stannane Chemical compound C=1C=CC=CC=1C(C[Sn](I)(I)I)C1=CC=CC=C1 FLHJWTVEWXPCJX-UHFFFAOYSA-K 0.000 description 1
- ARBGBCQCAFWNDH-UHFFFAOYSA-N 2-methoxy-4-(1,3-thiazolidin-2-yl)phenol Chemical compound C1=C(O)C(OC)=CC(C2SCCN2)=C1 ARBGBCQCAFWNDH-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- 101100037762 Caenorhabditis elegans rnh-2 gene Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229940045985 antineoplastic platinum compound Drugs 0.000 description 1
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 125000005587 carbonate group Chemical group 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- OPPINNAXNFZQLG-UHFFFAOYSA-M chloro-bis(4-methylphenyl)tin Chemical compound C1=CC(C)=CC=C1[Sn](Cl)C1=CC=C(C)C=C1 OPPINNAXNFZQLG-UHFFFAOYSA-M 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- JLAOLGQVKOWVNT-UHFFFAOYSA-N cyclohexyl(triphenyl)stannane Chemical compound C1CCCCC1[Sn](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 JLAOLGQVKOWVNT-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- RJGHQTVXGKYATR-UHFFFAOYSA-L dibutyl(dichloro)stannane Chemical compound CCCC[Sn](Cl)(Cl)CCCC RJGHQTVXGKYATR-UHFFFAOYSA-L 0.000 description 1
- PKKGKUDPKRTKLJ-UHFFFAOYSA-L dichloro(dimethyl)stannane Chemical compound C[Sn](C)(Cl)Cl PKKGKUDPKRTKLJ-UHFFFAOYSA-L 0.000 description 1
- MGAUKEZPAMVFNT-UHFFFAOYSA-L dichloro-bis(2-methylphenyl)stannane Chemical compound CC1=CC=CC=C1[Sn](Cl)(Cl)C1=CC=CC=C1C MGAUKEZPAMVFNT-UHFFFAOYSA-L 0.000 description 1
- BXVLQFGQYHYURU-UHFFFAOYSA-N diethyltin Chemical compound CC[Sn]CC BXVLQFGQYHYURU-UHFFFAOYSA-N 0.000 description 1
- PWEVMPIIOJUPRI-UHFFFAOYSA-N dimethyltin Chemical compound C[Sn]C PWEVMPIIOJUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 231100001095 no nephrotoxicity Toxicity 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- CKWIFRIQLGNJJQ-UHFFFAOYSA-N oxo-phenyl-propyltin Chemical compound CCC[Sn](=O)C1=CC=CC=C1 CKWIFRIQLGNJJQ-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- ODOPKAJVFRHHGM-UHFFFAOYSA-N phenyltin Chemical compound [Sn]C1=CC=CC=C1 ODOPKAJVFRHHGM-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003057 platinum Chemical class 0.000 description 1
- 150000003058 platinum compounds Chemical class 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000004001 thioalkyl group Chemical group 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- SKLQBHROODDCHR-UHFFFAOYSA-N trityltin Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)([Sn])C1=CC=CC=C1 SKLQBHROODDCHR-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2224—Compounds having one or more tin-oxygen linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/22—Tin compounds
- C07F7/2208—Compounds having tin linked only to carbon, hydrogen and/or halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8003160 | 1980-05-30 | ||
| NL8003160 | 1980-05-30 | ||
| NL8102269A NL8102269A (nl) | 1980-05-30 | 1981-05-08 | Tinverbindingen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijke tinverbinding voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel. |
| NL8102269 | 1981-05-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU83398A1 true LU83398A1 (fr) | 1981-09-11 |
Family
ID=26645628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU83398A LU83398A1 (fr) | 1980-05-30 | 1981-05-29 | Composes d'etain utiles comme medicament,medicament obtenu et procede de preparation dudit medicament |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4547320A (de) |
| AR (2) | AR225517A1 (de) |
| AU (1) | AU7115181A (de) |
| DD (2) | DD208357A5 (de) |
| DE (1) | DE3121551A1 (de) |
| DK (1) | DK236681A (de) |
| ES (3) | ES502621A0 (de) |
| FI (1) | FI811662L (de) |
| FR (1) | FR2483424B1 (de) |
| GB (1) | GB2077266A (de) |
| GR (1) | GR78341B (de) |
| IL (1) | IL62987A0 (de) |
| IT (1) | IT8122036A0 (de) |
| LU (1) | LU83398A1 (de) |
| NL (1) | NL8102269A (de) |
| NO (1) | NO811813L (de) |
| NZ (1) | NZ197240A (de) |
| PT (1) | PT73102B (de) |
| SE (1) | SE8103404L (de) |
| YU (2) | YU137581A (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0484596A1 (de) * | 1990-11-06 | 1992-05-13 | Pharmachemie B.V. | Organozinn-Verbindungen und diese enthaltende Antitumormittel |
| CN102424693B (zh) * | 2011-10-10 | 2014-02-12 | 聊城大学 | 四-2,6-吡啶二羧酸-二-（二茂铁双甲酸）三苯基锡配合物及其制备方法与应用 |
| CN102391314B (zh) * | 2011-11-29 | 2013-09-11 | 聊城大学 | 2,6-吡啶二羧酸-（二茂铁单甲酸）三苯基锡配合物及其制备方法与应用 |
| ES2843489T3 (es) | 2013-09-26 | 2021-07-19 | Asahi Chemical Ind | Compuesto de alquil estaño |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2597920A (en) * | 1951-06-29 | 1952-05-27 | Goodrich Co B F | Organo-tin compounds and composition including same and method of making same |
| US2867642A (en) * | 1956-09-18 | 1959-01-06 | Metal & Thermit Corp | Divinyltin oxide and method of preparation |
| FR1298303A (fr) * | 1956-09-18 | 1962-07-13 | Metal & Thermit Corp | Nouveau composé vinyl-stannique et procédé de préparation de ce composé |
| US3226292A (en) * | 1962-04-18 | 1965-12-28 | Dow Chemical Co | Bis(tripropyltin) oxide anthelmintic composition and method of using same |
-
1981
- 1981-02-16 GR GR65105A patent/GR78341B/el unknown
- 1981-05-08 NL NL8102269A patent/NL8102269A/nl not_active Application Discontinuation
- 1981-05-29 GB GB8116521A patent/GB2077266A/en not_active Withdrawn
- 1981-05-29 NO NO811813A patent/NO811813L/no unknown
- 1981-05-29 NZ NZ197240A patent/NZ197240A/en unknown
- 1981-05-29 IT IT8122036A patent/IT8122036A0/it unknown
- 1981-05-29 IL IL62987A patent/IL62987A0/xx unknown
- 1981-05-29 DE DE19813121551 patent/DE3121551A1/de not_active Withdrawn
- 1981-05-29 AU AU71151/81A patent/AU7115181A/en not_active Abandoned
- 1981-05-29 YU YU01375/81A patent/YU137581A/xx unknown
- 1981-05-29 ES ES502621A patent/ES502621A0/es active Granted
- 1981-05-29 DK DK236681A patent/DK236681A/da not_active Application Discontinuation
- 1981-05-29 SE SE8103404A patent/SE8103404L/ not_active Application Discontinuation
- 1981-05-29 PT PT73102A patent/PT73102B/pt unknown
- 1981-05-29 AR AR285502A patent/AR225517A1/es active
- 1981-05-29 LU LU83398A patent/LU83398A1/fr unknown
- 1981-05-29 FR FR8110746A patent/FR2483424B1/fr not_active Expired
- 1981-05-29 FI FI811662A patent/FI811662L/fi not_active Application Discontinuation
- 1981-06-01 DD DD81247594A patent/DD208357A5/de unknown
- 1981-06-01 DD DD81230468A patent/DD159641A5/de unknown
-
1982
- 1982-03-08 AR AR288670A patent/AR226504A1/es active
- 1982-06-01 ES ES512754A patent/ES512754A0/es active Granted
- 1982-06-01 ES ES512755A patent/ES512755A0/es active Granted
- 1982-09-13 US US06/417,091 patent/US4547320A/en not_active Expired - Fee Related
-
1983
- 1983-06-20 YU YU01351/83A patent/YU135183A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES8304582A1 (es) | 1983-03-01 |
| ES8304581A1 (es) | 1983-03-01 |
| AR226504A1 (es) | 1982-07-15 |
| ES512755A0 (es) | 1983-03-01 |
| NZ197240A (en) | 1984-07-06 |
| GR78341B (de) | 1984-09-26 |
| IL62987A0 (en) | 1981-07-31 |
| US4547320A (en) | 1985-10-15 |
| YU135183A (en) | 1983-12-31 |
| DD159641A5 (de) | 1983-03-23 |
| FR2483424B1 (fr) | 1985-10-25 |
| FI811662L (fi) | 1981-12-01 |
| IT8122036A0 (it) | 1981-05-29 |
| NO811813L (no) | 1981-12-01 |
| AR225517A1 (es) | 1982-03-31 |
| SE8103404L (sv) | 1981-12-01 |
| ES8300780A1 (es) | 1982-11-01 |
| ES512754A0 (es) | 1983-03-01 |
| GB2077266A (en) | 1981-12-16 |
| YU137581A (en) | 1983-12-31 |
| DE3121551A1 (de) | 1982-04-22 |
| DD208357A5 (de) | 1984-05-02 |
| PT73102B (en) | 1985-01-08 |
| ES502621A0 (es) | 1982-11-01 |
| FR2483424A1 (fr) | 1981-12-04 |
| PT73102A (en) | 1981-06-01 |
| DK236681A (da) | 1981-12-01 |
| NL8102269A (nl) | 1981-12-16 |
| AU7115181A (en) | 1981-12-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LU81470A1 (fr) | Complexes platine-diamine,procede d'obtention,application d'un tel complexe pour l'obtention d'un medicament pour le traitement du cancer et medicament ainsi obtenu | |
| FR2534907A1 (fr) | Complexes diamine-platine, un procede pour leur preparation, un procede pour la preparation d'une composition medicinale utilisant un tel complexe diamine platine pour le traitement du cancer ainsi que la composition ainsi formee | |
| EP0151072B1 (de) | Methylendiphosphonsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende antirheumatische Arzneimittel | |
| EP0073161A1 (de) | Pyridazin-Derivate mit einer Wirkung auf das Zentralnervensystem | |
| LU83398A1 (fr) | Composes d'etain utiles comme medicament,medicament obtenu et procede de preparation dudit medicament | |
| EP0364350B1 (de) | 4-Methyl-5[2-(4-phenyl-1-piperazinyl)-ethyl]-Thiazolderivate, ihre Herstellung und Zusammenstellungen, die sie enthalten | |
| FR2483425A1 (fr) | Composes de germanium, procede d'obtention de medicaments les contenant et medicaments ainsi obtenus | |
| EP0318392A1 (de) | N-(vinblastinoyl-23)-Derivate von 1-Aminomethylposphonsäure, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| FR2509725A1 (fr) | (hydroxyalkyl)phenylsulfures, leurs procedes de preparation et compositions pharmaceutiques les contenant | |
| EP1230252A1 (de) | Beta-d-thioxylos-derivate, verfahren zur herstellung und verwendung als arzneimittel | |
| EP0322236B1 (de) | Katalytisches Verfahren zur Herstellung von optisch aktivem Threonin | |
| EP0080271A1 (de) | Indomethacinphenylester-Derivate, ihre Verwendung und diese enthaltende Zusammensetzungen | |
| EP0151052B1 (de) | Aminoäthylimidazole, pharmazeutische Zusammensetzungen die sie enthalten und Verfahren zu ihrer Herstellung | |
| EP0082040B1 (de) | 3,7a-Diazacyclohepta(j,k)fluorenderivate, ihre Herstellung und ihre therapeutische Verwendung | |
| EP0067106B1 (de) | Phenoläther auf das herzgefässsystem wirkend, Verfahren zur Herstellung und Verwendung in Arzneimitteln | |
| EP0249556B1 (de) | Herstellungsverfahren von alpha-halogenierten organischen Carbonatestern | |
| FR2478094A1 (fr) | Derives de cinnamylmoranoline a substitution ammonio, a activite d'inhibition de l'augmentation de niveau de sucre dans le sang | |
| CH645096A5 (fr) | Derives benzylideniques, leur preparation et composition pharmaceutique les contenant. | |
| EP0403318A1 (de) | Verfahren zur Herstellung eines Antitumormittels, 3-Amino-1-(2-amino-1H-imidazolyl-4)-2-chloro-1-propanol in threoracemischer Form, verwendbar als Arzneimittel | |
| SU866966A1 (ru) | Бис (арилселенометиловые)эфиры,про вл ющие противовоспалительную и анальгетическую активности | |
| EP0346235A1 (de) | Verfahren zur Herstellung von N-(23-Vinblastinoyl) Derivaten des 1-Aminomethylphosphonsäures | |
| FR2533561A1 (fr) | Procede de preparation des carbamates vinyliques et nouveaux carbamates vinyliques | |
| EP0347305A1 (de) | [(Aryl-4-piperazinyl-1)-2-ethoxy]-3p-cymole, die ortho-, meta-, para-monosubstituierten oder disubstituierten Derivate, das Verfahren zu deren Herstellung und die als aktives Prinzip diese Verbindungen enthaltenden Arzneimittel | |
| FR2499993A1 (fr) | Sels de 2, 4, 8-triazaphenalenium et procede pour leur preparation | |
| FR2511364A1 (fr) | Derives d'acides (4-cycloalkyl-naphtyl) methylene aminooxy alcanoiques, procede d'obtention et application en therapeutique |